Works matching DE "BROMODOMAIN-containing proteins"


Results: 254
    1

    Histone Deacetylation in Alzheimer's Diseases (AD); Hope or Hype.

    Published in:
    Cell Biochemistry & Biophysics, 2025, v. 83, n. 2, p. 1537, doi. 10.1007/s12013-025-01670-0
    By:
    • Ateya, Nabaa Hisham;
    • Al-Taie, Sarah F.;
    • Jasim, Saade Abdalkareem;
    • Uthirapathy, Subasini;
    • Chaudhary, Kamlesh;
    • Rani, Pooja;
    • Kundlas, Mayank;
    • Naidu, K. Satyam;
    • Amer, Nevin Adel;
    • Ahmed, Jawad Kadhim
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer.

    Published in:
    Cancers, 2024, v. 16, n. 11, p. 1962, doi. 10.3390/cancers16111962
    By:
    • Andrikopoulou, Angeliki;
    • Bletsa, Garyfalia;
    • Rouvalis, Angeliki;
    • Tsakogiannis, Dimitris;
    • Kaparelou, Maria;
    • Papatheodoridi, Alkistis;
    • Haidopoulos, Dimitrios;
    • Liontos, Michalis;
    • Dimopoulos, Meletios-Athanasios;
    • Zagouri, Flora
    Publication type:
    Article
    15
    16
    17
    18
    19

    The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth.

    Published in:
    Cancers, 2023, v. 15, n. 15, p. 3851, doi. 10.3390/cancers15153851
    By:
    • Shukla, Sanjeev;
    • Riveros, Carlos;
    • Al-Toubat, Mohammed;
    • Chardon-Robles, Jonathan;
    • Osumi, Teruko;
    • Serrano, Samuel;
    • Kase, Adam M.;
    • Petit, Joachim L.;
    • Meurice, Nathalie;
    • Gleba, Justyna;
    • Copland III, John A.;
    • Chauhan, Jay;
    • Fletcher, Steven;
    • Balaji, K. C.
    Publication type:
    Article
    20
    21
    22
    23

    Functional Roles of Bromodomain Proteins in Cancer.

    Published in:
    Cancers, 2021, v. 13, n. 14, p. 3606, doi. 10.3390/cancers13143606
    By:
    • Boyson, Samuel P.;
    • Gao, Cong;
    • Quinn, Kathleen;
    • Boyd, Joseph;
    • Paculova, Hana;
    • Frietze, Seth;
    • Glass, Karen C.
    Publication type:
    Article
    24

    Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows a Strong Prognostic Value in Triple Negative Breast Cancer Patients.

    Published in:
    Cancers, 2021, v. 13, n. 6, p. 1246, doi. 10.3390/cancers13061246
    By:
    • Sanz-Álvarez, Marta;
    • Cristóbal, Ion;
    • Luque, Melani;
    • Santos, Andrea;
    • Zazo, Sandra;
    • Madoz-Gúrpide, Juan;
    • Caramés, Cristina;
    • Chiang, Cheng-Ming;
    • García-Foncillas, Jesús;
    • Eroles, Pilar;
    • Albanell, Joan;
    • Rojo, Federico;
    • Hurvitz, Sara A.
    Publication type:
    Article
    25
    26
    27
    28
    29

    Two faces of BRD4.

    Published in:
    Transcription (2154-1264), 2013, v. 4, n. 1, p. 13, doi. 10.4161/trns.22542
    By:
    • Devaiah, Ballachanda N.;
    • Singer, Dinah S.
    Publication type:
    Article
    30
    31
    32
    33
    34
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    BRD4: an effective target for organ fibrosis.

    Published in:
    Biomarker Research, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40364-024-00641-6
    By:
    • Wei, Qun;
    • Gan, Cailing;
    • Sun, Meng;
    • Xie, Yuting;
    • Liu, Hongyao;
    • Xue, Taixiong;
    • Deng, Conghui;
    • Mo, Chunheng;
    • Ye, Tinghong
    Publication type:
    Article
    48
    49
    50